6-bromo-2-methylimidazo[1,2-a]pyridine - CAS 4044-99-9
Catalog: |
BB024501 |
Product Name: |
6-bromo-2-methylimidazo[1,2-a]pyridine |
CAS: |
4044-99-9 |
Synonyms: |
6-bromo-2-methylimidazo[1,2-a]pyridine; 6-bromo-2-methylimidazo[1,2-a]pyridine |
IUPAC Name: | 6-bromo-2-methylimidazo[1,2-a]pyridine |
Description: | 6-bromo-2-methylimidazo[1,2-a]pyridine (CAS# 4044-99-9) is a useful research chemical. |
Molecular Weight: | 211.062 |
Molecular Formula: | C8H7BrN2 |
Canonical SMILES: | CC1=CN2C=C(C=CC2=N1)Br |
InChI: | InChI=1S/C8H7BrN2/c1-6-4-11-5-7(9)2-3-8(11)10-6/h2-5H,1H3 |
InChI Key: | TVHRDJPRECFZQO-UHFFFAOYSA-N |
Density: | 1.6 g/cm3 |
MDL: | MFCD09800594 |
LogP: | 2.40520 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021174164-A1 | Compounds and methods for modulating splicing | 20200228 |
WO-2021126729-A1 | Prmt5 inhibitors | 20191217 |
WO-2020201773-A1 | Mettl3 inhibitory compounds | 20190405 |
WO-2020141439-A1 | Heterocyclic compounds as mutant idh inhibitors | 20181231 |
WO-2020004594-A1 | Prophylactic or therapeutic agent for spinal muscular atrophy | 20180627 |
Complexity: | 151 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 209.97926 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 209.97926 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 17.3 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.9 |
-
Catalog: BB061033
((2R,5S,10aS,10bS)-10b-Hydroxy-5-isopropyl-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)carbamic Acid Benzyl Ester
Detail
-
Catalog: BB069173
((1-Chloro-2-methylpropan-2-yl)oxy)trimethylsilane
Detail
-
Catalog: BB071775
((1R,4R)-4-(((tert-butyldimethylsilyl)oxy)methyl)cyclohexyl)methanol
Detail
-
Catalog: BB074213
((2R,3S,4R,5R,6R)-5-Acetamido-3,4-dihydroxy-6-(2-(trimethylsilyl)ethoxy)tetrahydro-2H-pyran-2-yl)methyl 4-Methylbenzenesulfonate
Detail
-
Catalog: BB067784
((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanamine
Detail
-
Catalog: BB069926
((2R,4R)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
-
Catalog: BB056966
(((3aS,5aR,8aR,8bS)-2,2,7,7-Tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl)-L-arginine
Detail
-
Catalog: BB069924
((2S,4S)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS